Boston Scientific (Natick Massachusetts) is taking a huge leap ahead of the competition with the FDA approval of its Taxus Liberté Atom paclitaxel-eluting coronary stent system. The company said that, with this approval, it has a DES for use in vessels as small as 2.25 mm in diameter – something it says no other company has on the market. (Medical Device Daily)

ATLANTA – If Wednesday's luncheon at the 2009 annual meeting of the Biotechnology Industry Organization (Washington), which featured political heavyweights from both sides of the political aisle, could be looked at as a preview to the healthcare reform debate, then the U.S. is in for some interesting and rousing discussions in the coming months. (Medical Device Daily)